NCT06736704 2026-03-13
SNV4818 in Participants With Advanced Solid Tumors
Pikavation Therapeutics, Inc.
Phase 1/2 Recruiting
Pikavation Therapeutics, Inc.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
LigaChem Biosciences, Inc.
Akeso
Astellas Pharma Inc